ApprovalTrail

Approval · Notice of Compliance 30638 · 2023

ADDNUTRIV: Notice of Compliance 30638

Issued May 3, 2023

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
30638
Date
May 3, 2023
Company
Fresenius Kabi Canada LtdToronto, Ontario, Canada
Product type
Prescription Pharmaceutical
Submission
Supplement to a New Drug Submission (SNDS), supplement
Submission class
Other
Reason
Alternate drug substance supplier

Products in this notice

BrandDINStatus today
ADDNUTRIVNot yet assigned—

Medicinal ingredients